Cortisol as a Prognostic Marker of Short-Term Outcome in Chinese Patients with Acute Ischemic Stroke
Authors:
Open Access
- 12 September 2013
- journal article
- retracted article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e72758
Abstract
Early prediction of outcome is important for allocation of therapeutic strategies. Endocrine alterations of the hypothalamus–pituitary–axis are one of the first stress-induced alterations after cerebral ischemia. We therefore evaluated the prognostic value of serum cortisol in Chinese patients with an acute ischemic stroke. In a prospective observational study, serum cortisol was measured using a solid-phase, competitive chemiluminescent enzyme immunoassay on admission in serum of 226 consecutive Chinese patients with an acute ischemic stroke. The prognostic value of serum cortisol to predict the functional outcome, mortality within 90 days, was compared with clinical variables (e.g., advanced age and the National Institutes of Health Stroke Scale [NHISS] score) and with other known predictors. Patients with a poor outcome and nonsurvivors had significantly increased serum cortisol levels on admission (P<0.0001, P<0.0001). There was a positive correlation between levels of cortisol and the NIHSS (r = 0.298, P<0.0001), glucose levels (r = 0.324, P<0.0001) and infarct volume (r = 0.328, P<0.0001). Cortisol was an independent prognostic marker of functional outcome and death [odds ratio 3.44 (2.58–6.23) and 4.21 (1.89–9.24), respectively, P<0.0001 for both, adjusted for age, the NIHSS and other predictors] in patients with ischemic stroke. In receiver operating characteristic curve analysis, cortisol could improve the NIHSS score in predicting short-term functional outcome (Area under the curve [AUC] of the combined model, 0.87; 95% CI, 0.82–0.92; P = 0.01) and mortality (AUC of the combined model, 0.90; 95% CI, 0.84–0.95; P = 0.01). Cortisol can be seen as an independent short-term prognostic marker of functional outcome and death in Chinese patients with acute ischemic stroke even after correcting confounding factors. Combined model can add significant additional predictive information to the clinical score of the NIHSS.Keywords
This publication has 35 references indexed in Scilit:
- Diurnal Cortisol and Functional Outcomes in Post-Acute Rehabilitation PatientsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Cortisol and adrenocorticotropic hormone dynamics in the acute phase of subarachnoid haemorrhageBritish Journal Of Neurosurgery, 2011
- High serum cortisol level is associated with increased risk of delirium after coronary artery bypass graft surgery: a prospective cohort studyCritical Care, 2010
- Copeptin and risk stratification in patients with acute dyspneaCritical Care, 2010
- The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A HypothesisThe Journal of Clinical Endocrinology & Metabolism, 2009
- ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumesNeurology, 2009
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Stress hormone and blood glucose response following acute stroke in the elderly.Stroke, 1991
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989
- Recovery of motor function after stroke.Stroke, 1988